Expression of miR‑495 and miR‑326 in peripheral blood of rheumatoid arthritis patients and its significance

Sui,Xiaojuan; Liu,Huiping; Zhou,Yanli

doi:10.3892/etm.2020.9124

Expression of miR‑495 and miR‑326 in peripheral blood of rheumatoid arthritis patients and its significance

Authors:
- Xiaojuan Sui
- Huiping Liu
- Yanli Zhou
View Affiliations

Affiliations: Department of Orthopaedics, Yidu Central Hospital of Weifang, Weifang, Shandong 261000, P.R. China, Department of Neurology, Anqiu People's Hospital, Anqiu, Shandong 262100, P.R. China
Published online on: August 19, 2020 https://doi.org/10.3892/etm.2020.9124
Pages: 3766-3774
Copyright: © Sui et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the expression of microRNA (miR)-495 and miR‑326 in the peripheral blood of patients with rheumatoid arthritis (RA). A total of 107 RA patients, admitted to the Yidu Central Hospital of Weifang (Weifang, China) from February 2016 to February 2019, and 112 healthy subjects, who underwent physical examination during the same period, were selected as the research subjects for prospective analysis. The RA patients served as the study group and the healthy subjects as the control group. The expression levels of miR‑495 and miR‑326 in the peripheral blood of the two groups of subjects were compared. The association between miR‑495 and miR‑326 with RA clinical pathology and the diagnostic value of miR‑495 and miR‑326 for RA were analyzed. In the study group, miR‑495 expression was significantly higher than that in the control group, and miR‑326 expression was significantly lower than that in the control group (P<0.001). miR‑495 and miR‑326 combined diagnosis showed good predictive value for the occurrence of RA (P<0.001) and was closely related to RA clinical pathology (P<0.001). After treatment, miR‑495 expression was significantly decreased in the study group, whereas miR‑326 expression was significantly increased (P<0.001). Pearson's correlation coefficient analysis showed that rheumatoid factor (RF) was positively correlated with miR‑495 expression and negatively correlated with miR‑326 expression (P<0.001). In conclusion, miR‑495 was highly expressed in patients with RA, whereas miR‑326 was poorly expressed in RA patients, and the combined detection of miR‑495 and miR‑326 has good diagnostic value for RA.

View Figures

View References

1	Mankia K and Emery P: Preclinical rheumatoid arthritis: Progress toward prevention. Arthritis Rheumatol. 68:779–788. 2016.PubMed/NCBI View Article : Google Scholar
2	Firestein GS and McInnes IB: Immunopathogenesis of rheumatoid arthritis. Immunity. 46:183–196. 2017.PubMed/NCBI View Article : Google Scholar
3	Simon TA, Thompson A, Gandhi KK, Hochberg MC and Suissa S: Incidence of malignancy in adult patients with rheumatoid arthritis: A meta-analysis. Arthritis Res Ther. 17(212)2015.PubMed/NCBI View Article : Google Scholar
4	Myasoedova E, Crowson CS, Kremers HM, Therneau TM and Gabriel SE: Is the incidence of rheumatoid arthritis rising?: Results from olmsted county, minnesota, 1955-2007. Arthritis Rheum. 62:1576–1582. 2010.PubMed/NCBI View Article : Google Scholar
5	McInnes IB and Schett G: Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 389:2328–2337. 2017.PubMed/NCBI View Article : Google Scholar
6	Burmester GR and Pope JE: Novel treatment strategies in rheumatoid arthritis. Lancet. 389:2338–2348. 2017.PubMed/NCBI View Article : Google Scholar
7	Stoffer MA, Schoels MM, Smolen JS, Aletaha D, Breedveld FC, Burmester G, Bykerk V, Dougados M, Emery P, Haraoui B, et al: Evidence for treating rheumatoid arthritis to target: Results of a systematic literature search update. Ann Rheum Dis. 75:16–22. 2016.PubMed/NCBI View Article : Google Scholar
8	Nikiphorou E, Norton S, Young A, Carpenter L, Dixey J, Walsh DA and Kiely P: ERAS and ERAN. Association between rheumatoid arthritis disease activity, progression of functional limitation and long-term risk of orthopaedic surgery: Combined analysis of two prospective cohorts supports EULAR treat to target DAS thresholds. Ann Rheum Dis. 75:2080–2086. 2016.PubMed/NCBI View Article : Google Scholar
9	Aletaha D and Smolen JS: Diagnosis and management of rheumatoid arthritis: A review. JAMA. 320:1360–1372. 2018.PubMed/NCBI View Article : Google Scholar
10	Gavrilă BI, Ciofu C and Stoica V: Biomarkers in rheumatoid arthritis, what is new? J Med Life. 9:144–148. 2016.PubMed/NCBI
11	Rupaimoole R and Slack FJ: MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 16:203–222. 2017.PubMed/NCBI View Article : Google Scholar
12	Welten SM, Bastiaansen AJ, de Jong RC, de Vries MR, Peters EA, Boonstra MC, Sheikh SP, La Monica N, Kandimalla ER, Quax PH and Nossent AY: Inhibition of 14q32 MicroRNAs miR-329, miR-487b, miR-494, and miR-495 increases neovascularization and blood flow recovery after ischemia. Circ Res. 115:696–708. 2014.PubMed/NCBI View Article : Google Scholar
13	Yang DW, Qian GB, Jiang MJ, Wang P and Wang KZ: Inhibition of microRNA-495 suppresses chondrocyte apoptosis through activation of the NF-κB signaling pathway by regulating CCL4 in osteoarthritis. Gene Ther. 26:217–229. 2019.PubMed/NCBI View Article : Google Scholar
14	Zhou J, Xu T, Yan Y, Qin R, Wang H, Zhang X, Huang Y, Wang Y, Lu Y, Fu D and Chen J: MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1). PLoS One. 8(e68469)2013.PubMed/NCBI View Article : Google Scholar
15	Wang J, Cao L, Wu J and Wang Q: Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma. Int J Oncol. 52:77–88. 2018.PubMed/NCBI View Article : Google Scholar
16	Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, Kvien TK, Navarro-Compán MV, Oliver S, Schoels M, et al: Treating rheumatoid arthritis to target: 2014 Update of the recommendations of an international task force. Ann Rheum Dis. 75:3–15. 2016.PubMed/NCBI View Article : Google Scholar
17	Perkins JR, Dawes JM, McMahon SB, Bennett DL, Orengo C and Kohl M: ReadqPCR and NormqPCR: R packages for the reading, quality checking and normalisation of RT-qPCR quantification cycle (Cq) data. BMC Genomics. 13(296)2012.PubMed/NCBI View Article : Google Scholar
18	Tobón GJ, Youinou P and Saraux A: The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis. Autoimmun Rev. 9:A288–A292. 2010.PubMed/NCBI View Article : Google Scholar
19	Chiu HY, Huang HL, Li CH, Chen HA, Yeh CL, Chiu SH, Lin WC, Cheng YP, Tsai TF and Ho SY: Increased risk of chronic kidney disease in rheumatoid arthritis associated with cardiovascular complications-a national population-based cohort study. PLoS One. 10(e0136508)2015.PubMed/NCBI View Article : Google Scholar
20	Ito H, Kojima M, Nishida K, Matsushita I, Kojima T, Nakayama T, Endo H, Hirata S, Kaneko Y, Kawahito Y, et al: Postoperative complications in patients with rheumatoid arthritis using a biological agent-a systematic review and meta-analysis. Mod Rheumatol. 25:672–678. 2015.PubMed/NCBI View Article : Google Scholar
21	Clark AL, Maruyama S, Sano S, Accorsi A, Girgenrath M, Walsh K and Naya FJ: miR-410 and miR-495 are dynamically regulated in diverse cardiomyopathies and their inhibition attenuates pathological hypertrophy. PLoS One. 11(e0151515)2016.PubMed/NCBI View Article : Google Scholar
22	Kefas B, Comeau L, Erdle N, Montgomery E, Amos S and Purow B: Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells. Neuro Oncol. 12:1102–1112. 2010.PubMed/NCBI View Article : Google Scholar
23	Lee S, Yoon DS, Paik S, Lee KM, Jang Y and Lee JW: microRNA-495 inhibits chondrogenic differentiation in human mesenchymal stem cells by targeting Sox9. Stem Cells Dev. 23:1798–1808. 2014.PubMed/NCBI View Article : Google Scholar
24	Tanaka Y: Human mesenchymal stem cells as a tool for joint repair in rheumatoid arthritis. Clin Exp Rheumatol. 33 (Suppl 92):S58–S62. 2015.PubMed/NCBI
25	Gao W, Sweeney C, Connolly M, Kennedy A, Ng CT, McCormick J, Veale DJ and Fearon U: Notch-1 mediates hypoxia-induced angiogenesis in rheumatoid arthritis. Arthritis Rheum. 64:2104–2113. 2012.PubMed/NCBI View Article : Google Scholar
26	Zhang X, Yang Y and Feng Z: Suppression of microRNA-495 alleviates high-glucose-induced retinal ganglion cell apoptosis by regulating Notch/PTEN/Akt signaling. Biomed Pharmacother. 106:923–929. 2018.PubMed/NCBI View Article : Google Scholar
27	Mao Y, Li L, Liu J, Wang L and Zhou Y: miR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1. Oncotarget. 7:51223–51236. 2016.PubMed/NCBI View Article : Google Scholar
28	Formosa A, Markert EK, Lena AM, Italiano D, Finazzi-Agro' E, Levine AJ, Bernardini S, Garabadgiu AV, Melino G and Candi E: MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene. 33:5173–5182. 2014.PubMed/NCBI View Article : Google Scholar
29	Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S, Li Z, Wu Z and Pei G: MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol. 10:1252–1259. 2009.PubMed/NCBI View Article : Google Scholar
30	Wernert N, Justen HP, Rothe M, Behrens P, Dreschers S, Neuhaus T, Florin A, Sachinidis A, Vetter H and Ko Y: The Ets 1 transcription factor is upregulated during inflammatory angiogenesis in rheumatoid arthritis. J Mol Med (Berl). 80:258–266. 2002.PubMed/NCBI View Article : Google Scholar
31	Du W, Yin L, Tong P, Chen J, Zhong Y, Huang J and Duan S: miR-495 targeting dvl-2 represses the inflammatory response of ankylosing spondylitis. Am J Transl Res. 11:2742–2753. 2019.PubMed/NCBI
32	Tomofuji T, Yoneda T, Machida T, Ekuni D, Azuma T, Kataoka K, Maruyama T and Morita M: Micro RNA s as serum biomarkers for periodontitis. J Clin Periodontol. 43:418–425. 2016.PubMed/NCBI View Article : Google Scholar
33	García-Díaz D F, Pizarro C, Camacho-Guillén P, Codner E, Soto N and Pérez-Bravo F: Expression of miR-155, miR-146a, and miR-326 in T1D patients from Chile: Relationship with autoimmunity and inflammatory markers. Arch Endocrinol Metab. 62:34–40. 2018.PubMed/NCBI View Article : Google Scholar